Apr. 17 at 11:20 AM
$HLYK
NASDAQ uplisting is the main rocket here. They already filed a
$7M offering targeting a NASDAQ move, and recent proxy filings suggest key approvals are coming. Stock already running shows the market is front-running bigger exchange exposure and new buyers.
$DCGO
DocGo officially exploring strategic alternatives is Wall Street code for buyout, merger, or major deal. Add raised 2026 revenue guidance and improving margins, and this looks like a cheap healthcare asset getting noticed. If they clear
$1 compliance, momentum can hit fast.
$STUB
StubHub looks beaten down but loaded with upside. FTC settlement clears a major cloud, analysts see huge undervaluation, and profitability is expected this year. The Live Nation monopoly lawsuit could open more market share for rivals like StubHub, giving them a cleaner lane to grow and compete.
That’s my portfolio—three asymmetric plays with catalysts, where patience and positioning now could turn into serious money later.